Cargando…
低剂量螺旋CT肺癌筛查研究进展
Lung cancer has become the leading cause of cancer mortality globally, and 5-year survival rate is very poor. Screening and early detection are vital to improve survival and decrease mortality of lung cancer. In recent 20 years, low-dose spiral CT (LDCT) screening has become a research focus in this...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015170/ https://www.ncbi.nlm.nih.gov/pubmed/24113010 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.10 |
_version_ | 1783334349410664448 |
---|---|
collection | PubMed |
description | Lung cancer has become the leading cause of cancer mortality globally, and 5-year survival rate is very poor. Screening and early detection are vital to improve survival and decrease mortality of lung cancer. In recent 20 years, low-dose spiral CT (LDCT) screening has become a research focus in this area. Randomized controlled trials have confirmed that LDCT can decrease lung cancer mortality. However, there are still some problems of LDCT. In this paper, we summarized the controversy that whether low-dose helical CT screening can reduce lung cancer mortality or not before its effectiveness was been confirmed, the results and problems in the randomized controlled trials and gave a prospect of low-dose helical CT screening's future application. |
format | Online Article Text |
id | pubmed-6015170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60151702018-07-06 低剂量螺旋CT肺癌筛查研究进展 Zhongguo Fei Ai Za Zhi 综述 Lung cancer has become the leading cause of cancer mortality globally, and 5-year survival rate is very poor. Screening and early detection are vital to improve survival and decrease mortality of lung cancer. In recent 20 years, low-dose spiral CT (LDCT) screening has become a research focus in this area. Randomized controlled trials have confirmed that LDCT can decrease lung cancer mortality. However, there are still some problems of LDCT. In this paper, we summarized the controversy that whether low-dose helical CT screening can reduce lung cancer mortality or not before its effectiveness was been confirmed, the results and problems in the randomized controlled trials and gave a prospect of low-dose helical CT screening's future application. 中国肺癌杂志编辑部 2013-10-20 /pmc/articles/PMC6015170/ /pubmed/24113010 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.10 Text en 版权所有©《中国肺癌杂志》编辑部2013 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 综述 低剂量螺旋CT肺癌筛查研究进展 |
title | 低剂量螺旋CT肺癌筛查研究进展 |
title_full | 低剂量螺旋CT肺癌筛查研究进展 |
title_fullStr | 低剂量螺旋CT肺癌筛查研究进展 |
title_full_unstemmed | 低剂量螺旋CT肺癌筛查研究进展 |
title_short | 低剂量螺旋CT肺癌筛查研究进展 |
title_sort | 低剂量螺旋ct肺癌筛查研究进展 |
topic | 综述 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015170/ https://www.ncbi.nlm.nih.gov/pubmed/24113010 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.10 |